BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coelen RJS, de Keijzer MJ, Weijer R, Loukachov VV, Wiggers JK, Mul FPJ, van Wijk ACWA, Fong Y, Heger M, van Gulik TM. In vitro detection of cholangiocarcinoma cells using a fluorescent protein-expressing oncolytic herpes virus. Cancer Gene Ther 2017;24:227-32. [PMID: 28409558 DOI: 10.1038/cgt.2017.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Yoo SY, Badrinath N, Lee HL, Heo J, Kang DH. A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma. Cancers (Basel) 2019;11:E1667. [PMID: 31717883 DOI: 10.3390/cancers11111667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Woo Y, Reid V, Kelly KJ, Carlson D, Yu Z, Fong Y. Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer. Mol Ther Oncolytics 2020;16:1-6. [PMID: 31909180 DOI: 10.1016/j.omto.2019.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]